Your browser doesn't support javascript.
loading
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Scheffler, Matthias; Holzem, Alessandra; Kron, Anna; Nogova, Lucia; Ihle, Michaela A; von Levetzow, Cornelia; Fassunke, Jana; Wömpner, Claudia; Bitter, Elisabeth; Koleczko, Sophia; Abdulla, Diana S Y; Michels, Sebastian; Fischer, Rieke; Riedel, Richard; Weber, Jan-Philipp; Westphal, Theresa; Gerigk, Ulrich; Kern, Jens; Kaminsky, Britta; Randerath, Winfried; Kambartel, Karl-Otto; Merkelbach-Bruse, Sabine; Büttner, Reinhard; Wolf, Jürgen.
Afiliación
  • Scheffler M; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Holzem A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Kron A; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Nogova L; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Ihle MA; University of Cologne, Cologne Institute of Pathology, Cologne, Germany.
  • von Levetzow C; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Fassunke J; University of Cologne, Cologne Institute of Pathology, Cologne, Germany.
  • Wömpner C; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Bitter E; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Koleczko S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Abdulla DSY; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Michels S; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Fischer R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Riedel R; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Weber JP; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Westphal T; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany.
  • Gerigk U; GFO Clinics Bonn, Marien-Hospital Bonn, Bonn, Germany.
  • Kern J; KWM Missio Clinic, Würzburg, Germany.
  • Kaminsky B; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany.
  • Randerath W; Bethanien Hospital Solingen, Clinic for Pulmonology and Allergology, Solingen, Germany.
  • Kambartel KO; Bethanien Hospital Moers, Lung Center, Moers, Germany.
  • Merkelbach-Bruse S; University of Cologne, Cologne Institute of Pathology, Cologne, Germany.
  • Büttner R; University of Cologne, Cologne Institute of Pathology, Cologne, Germany.
  • Wolf J; University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.
Lung Cancer ; 144: 40-48, 2020 06.
Article en En | MEDLINE | ID: mdl-32361034

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania